A new method replicated the findings of a previous clinical trial of Tecfidera in people with relapsing-remitting MS, a study ...

The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...

(an Instem company), a leader in statistical computing infrastructure and clinical trial transparency, today announced the appointment of Christine Oliver as its President. Christine brings over two ...

Rapid antimicrobial susceptibility testing for gram-negative blood infections shows no improvement in clinical outcomes ...

As clinical development activity expands for psychedelic drug programs and other emerging CNS therapeutics, NetraMark believes that advanced, explainable analytics will become inc ...

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that detailed results from the ...

AI would identify new drug targets, generate molecules, and compress years of chemistry into weeks. Those promises were not ...

To address the limitations of binary pCR classification, Pusztai and colleagues developed the residual cancer burden (RCB) ...

Editorialists call for better screening of authors ...

When President Donald Trump announced Robert F. Kennedy Jr. as his pick for Health and Human Services secretary, he declared that the appointment marked the return of “Gold Standard Scie ...